Verma I - Search Results

1

Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.

Kalra M, Grover A, Mehta N, Singh J, Kaur J, Sable SB, Behera D, Sharma P, Verma I, Khuller GK. Kalra M, et al. Among authors: verma i. Clin Immunol. 2007 Nov;125(2):173-83. doi: 10.1016/j.clim.2007.07.007. Epub 2007 Sep 4. Clin Immunol. 2007. PMID: 17766185

2

Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra.

Sinha RK, Verma I, Khuller GK. Sinha RK, et al. Among authors: verma i. Vaccine. 1997 Apr-May;15(6-7):689-99. doi: 10.1016/s0264-410x(96)00230-7. Vaccine. 1997. PMID: 9178471

3

Immunoreactivity of mycobacterial 70 kDa protein in different physico-chemical forms.

Verma I, Yadav D, Sharma S, Sinha R, Khuller GK. Verma I, et al. Indian J Med Res. 1997 Jul;106:13-5. Indian J Med Res. 1997. PMID: 9248209

4

Cellular immune responses to cell wall peptidoglycan associated protein antigens in tuberculosis patients and healthy subjects.

Dhiman N, Verma I, Khuller GK. Dhiman N, et al. Among authors: verma i. Microbiol Immunol. 1997;41(6):495-502. doi: 10.1111/j.1348-0421.1997.tb01883.x. Microbiol Immunol. 1997. PMID: 9251061 Free article.

5

Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra.

Sharma S, Verma I, Khuller GK. Sharma S, et al. Among authors: verma i. Arch Microbiol. 1999 Apr;171(5):338-42. doi: 10.1007/s002030050719. Arch Microbiol. 1999. PMID: 10382264

6

Adjuvant modulation of T-cell reactivity to 30-kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis.

Sharma AK, Verma I, Tewari R, Khuller GK. Sharma AK, et al. Among authors: verma i. J Med Microbiol. 1999 Aug;48(8):757-763. doi: 10.1099/00222615-48-8-757. J Med Microbiol. 1999. PMID: 10450999

7

Alterations in macromolecular composition and cell wall integrity by ciprofloxacin in Mycobacterium smegmatis.

Verma I, Rohilla A, Khuller GK. Verma I, et al. Lett Appl Microbiol. 1999 Aug;29(2):113-7. doi: 10.1046/j.1365-2672.1999.00597.x. Lett Appl Microbiol. 1999. PMID: 10499299

8

Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study.

Sharma S, Verma I, Khuller GK. Sharma S, et al. Among authors: verma i. Eur Respir J. 2000 Jul;16(1):112-7. doi: 10.1034/j.1399-3003.2000.16a20.x. Eur Respir J. 2000. PMID: 10933095 Free article.

9

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis.

Sharma S, Verma I, Khuller GK. Sharma S, et al. Among authors: verma i. Antimicrob Agents Chemother. 2001 Feb;45(2):639-40. doi: 10.1128/AAC.45.2.639-640.2001. Antimicrob Agents Chemother. 2001. PMID: 11158773 Free PMC article.

10

Biochemical mechanism of combined effect of ethambutol and sparfloxacin against Mycobacterium smegmatis.

Kaur D, Verma I, Khuller GK. Kaur D, et al. Among authors: verma i. Indian J Exp Biol. 2001 Mar;39(3):238-42. Indian J Exp Biol. 2001. PMID: 11495282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,076 results

Search Page

Filters